Low semen quality linked to shorter lifespan

Researchers determine how low semen quality may impact mortality risk.

Silence unveils more PhI data for siRNA drug in new cardiovascular race targeting Lp(a)

Silence Therapeutics’ siRNA asset showed hints of efficacy in cardiovascular disease patients enrolled in a Phase I trial amid recent readouts from pipeline rivals backed

November 2, 2023

Freenome raises $254M to study cancer screening tests

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Freenome has raised $254 million

February 16, 2024

The Psychedelics Industry Hit Major Highs and Lows in 2024 | Psychedelic Invest

The psychedelics industry witnessed notable milestones and setbacks at both the state and federal levels in 2024. Here’s a detailed look at some of the

January 6, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.